Avihu Z. Gazit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Avihu Z. Gazit has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Charles B. Huddleston
Pediatric Cardiothoracic Surgery, St. Louis University, St. Louis, MO, USA
9 shared publicationsJames Fehr
6 shared publications- Pirooz Eghtesady
Department of Surgery, Division of Cardiothoracic Surgery, Washington University of St. Louis School of Medicine, St. Louis, MO 63108, USA
6 shared publications Stuart C. Sweet
Division of Pediatric Pulmonary Medicine Washington University in St. Louis St Louis Missouri USA
5 shared publicationsA. Thomas Pezzella
4 shared publicationsPaul A. Checchia
4 shared publications
Latest Publications
- 11 August 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 184, 69-76
Perioperative Brain Damage Biomarkers Predict Neurodevelopmental Delay After Infant Cardiac Surgery: A Multicenter Study
- 11 August 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 184, 69-76
Perioperative Brain Damage Biomarkers Predict Neurodevelopmental Delay After Infant Cardiac Surgery: A Multicenter Study
- 29 April 2025
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (7) , e1355-e1364
Risk Analytics Clinical Decision Support Decreases Duration of Vasoactive Infusions Following Pediatric Cardiac Surgery: A Multicenter Before and After Clinical Trial
Objectives: Our primary objective was to quantify the effect of a clinical decision support system (CDSS) informed by inadequate delivery of oxygen index (IDo 2), an algorithm that estimates the probability of inadequate oxygen delivery on inotropes and vasoactive infusions (IVAI) postoperatively. Design: Multicenter before-and-after study conducted between June 01, 2020, and December 31, 2022. Setting: Three pediatric cardiac ICUs (CICUs) at tertiary academic children’s hospitals. Patients: Infants older than 36 weeks estimated gestational age and 2 kg following cardiac surgery with cardiopulmonary bypass, treated with IVAI greater than or equal to 6 hours. Interventions: Clinicians committed to consider data from a CDSS informed by 6 hours rolling IDo 2 average in their plan to wean IVAI postoperatively. Within the system, documentation of decisions incorporating these data prompted patient inclusion in the intervention arm. Measurements and Main Results: The primary outcome measure was IVAI duration. Secondary outcomes were CICU length of stay (LOS), rate of cardiac arrest (CA), and rate of IVAI weaning failure. Negative binomial and logistic regression models were used to assess differences between intervention and control groups. Age, sex, Society of Thoracic Surgeons-European association for Cardio-Thoracic Surgery (STAT) category, site, admit time, single-ventricle diagnosis, Vasoactive-Inotropic Score, and trial group were tested as input covariates. Three hundred forty-three and 432 patients were enrolled in the intervention and control groups, respectively. The intervention group included a higher proportion of STAT 4 patients and a lower proportion of STAT 1 patients (81 vs. 62; p < 0.01 and 43 vs. 108; p < 0.01, respectively). A risk-adjusted negative binomial regression model showed 29% shorter vasoactive infusion duration in the intervention group (95% CI, 14–42%; p < 0.01). There were no significant trends observed in CICU LOS, or occurrence rate of CA or weaning failure. Conclusions: A CDSS informed by IDo 2 significantly decreased vasoactive infusions duration. There was no discernible change in ICU LOS, CA rate, or weaning failure rate.
- 29 April 2025
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (7) , e1355-e1364
Risk Analytics Clinical Decision Support Decreases Duration of Vasoactive Infusions Following Pediatric Cardiac Surgery: A Multicenter Before and After Clinical Trial
Objectives: Our primary objective was to quantify the effect of a clinical decision support system (CDSS) informed by inadequate delivery of oxygen index (IDo 2), an algorithm that estimates the probability of inadequate oxygen delivery on inotropes and vasoactive infusions (IVAI) postoperatively. Design: Multicenter before-and-after study conducted between June 01, 2020, and December 31, 2022. Setting: Three pediatric cardiac ICUs (CICUs) at tertiary academic children’s hospitals. Patients: Infants older than 36 weeks estimated gestational age and 2 kg following cardiac surgery with cardiopulmonary bypass, treated with IVAI greater than or equal to 6 hours. Interventions: Clinicians committed to consider data from a CDSS informed by 6 hours rolling IDo 2 average in their plan to wean IVAI postoperatively. Within the system, documentation of decisions incorporating these data prompted patient inclusion in the intervention arm. Measurements and Main Results: The primary outcome measure was IVAI duration. Secondary outcomes were CICU length of stay (LOS), rate of cardiac arrest (CA), and rate of IVAI weaning failure. Negative binomial and logistic regression models were used to assess differences between intervention and control groups. Age, sex, Society of Thoracic Surgeons-European association for Cardio-Thoracic Surgery (STAT) category, site, admit time, single-ventricle diagnosis, Vasoactive-Inotropic Score, and trial group were tested as input covariates. Three hundred forty-three and 432 patients were enrolled in the intervention and control groups, respectively. The intervention group included a higher proportion of STAT 4 patients and a lower proportion of STAT 1 patients (81 vs. 62; p < 0.01 and 43 vs. 108; p < 0.01, respectively). A risk-adjusted negative binomial regression model showed 29% shorter vasoactive infusion duration in the intervention group (95% CI, 14–42%; p < 0.01). There were no significant trends observed in CICU LOS, or occurrence rate of CA or weaning failure. Conclusions: A CDSS informed by IDo 2 significantly decreased vasoactive infusions duration. There was no discernible change in ICU LOS, CA rate, or weaning failure rate.
- 17 July 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (1)
Lung Re‐transplantation after prolonged veno‐venous extracorporeal membrane oxygenation (ECMO) in a child with chronic lung allograft dysfunction
Background: Extracorporeal Membrane Oxygenation (ECMO) may be used as a bridge to lung transplantation in selected patients with end‐stage respiratory failure. Historically, ECMO use in this setting has been associated with poor outcomes Puri V et.al, J Thorac Cardiovasc Surg, 140:427. More recently, technical advances and the implementation of rehabilitation and ambulation while awaiting transplantation on ECMO have led to improved surgical and post‐transplant outcomes Kirkby S et.al, J Thorac Dis, 6:1024.Methods: We illustrate the case of a 6‐year‐old child who received prolonged ECMO support as a bridge to lung re‐transplantation secondary to Chronic Lung Allograft Dysfunction (CLAD).Results: Early rehabilitation was key in improving the overall pre‐transplant conditioning during ECMO.Conclusions: Despite challenges associated with awake/ambulatory ECMO, the use of this strategy as a bridge to lung transplantation is feasible and has resulted in improved pre‐transplant conditioning and post‐transplant outcomes.
- 17 July 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (1)
Lung Re‐transplantation after prolonged veno‐venous extracorporeal membrane oxygenation (ECMO) in a child with chronic lung allograft dysfunction
Background: Extracorporeal Membrane Oxygenation (ECMO) may be used as a bridge to lung transplantation in selected patients with end‐stage respiratory failure. Historically, ECMO use in this setting has been associated with poor outcomes Puri V et.al, J Thorac Cardiovasc Surg, 140:427. More recently, technical advances and the implementation of rehabilitation and ambulation while awaiting transplantation on ECMO have led to improved surgical and post‐transplant outcomes Kirkby S et.al, J Thorac Dis, 6:1024.Methods: We illustrate the case of a 6‐year‐old child who received prolonged ECMO support as a bridge to lung re‐transplantation secondary to Chronic Lung Allograft Dysfunction (CLAD).Results: Early rehabilitation was key in improving the overall pre‐transplant conditioning during ECMO.Conclusions: Despite challenges associated with awake/ambulatory ECMO, the use of this strategy as a bridge to lung transplantation is feasible and has resulted in improved pre‐transplant conditioning and post‐transplant outcomes.
- Open Access
- 12 December 2019
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 7, 509
TEG Platelet Mapping and Impedance Aggregometry to Predict Platelet Transfusion During Cardiopulmonary Bypass in Pediatric Patients
Background: Cardiopulmonary bypass-related platelet dysfunction can increase the risk of intra- and post-operative bleeding in children undergoing cardiac surgery. More accurate laboratory tests that identify acquired platelet abnormalities could allow for rapid identification of patients at risk of bleeding and provide therapies that could reduce bleeding and platelet transfusions. We hypothesized that thromboelastography with platelet mapping (TEG-PM) and multiple electrode impedance aggregometry (MEIA) as functional measures of platelet function would predict who will require platelet transfusion. Our secondary hypothesis was that platelet aggregation at both arachidonic acid (AA) and adenosine diphosphate (ADP) receptors would correlate between TEG-PM and MEIA results. Methods: In this prospective study from August 2013 to December 2015, children from newborn to 5 years of age with congenital heart disease undergoing cardiopulmonary bypass had blood samples collected and analyzed at four time points: pre-bypass, post-bypass, post-operatively on arrival to the Cardiac Intensive Care Unit, and 24 h after arrival. Results: Of the 44 patients analyzed, the 10 patients who received peri-operative platelet transfusion were significantly younger (p = 0.05), had higher STAT (Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Mortality Categories (p < 0.002) and longer cardiopulmonary bypass times (p = 0.02). In univariate analysis, four variables were associated with peri-operative platelet transfusion: pre-operative age [OR 0.95 (0.93, 0.98), p = 0.03], cardiopulmonary bypass time [1.5 (1.31, 1.68), p = 0.008], STAT Mortality Category [3.64 (3.40, 3.87), p < 0.001], and TEG-PM ADP [0.79 (0.65, 0.93), p = 0.04]. ROC analysis demonstrated moderate predictive value of TEG-PM ADP with AUC of 0.745 (0.59, 0.91). A TEG-PM ADP value of less than or equal to 21 had 85% sensitivity and 70% specificity for platelet transfusion. In the multivariate analysis, only STAT Mortality Category predicted platelet transfusion. TEG-PM and MEIA results correlated for the AA receptor at all 4 time points, but the same tests at the ADP receptors did not correlate. Conclusions: TEG-PM ADP may provide more clinically relevant information regarding platelet function compared to the MEIA at the ADP receptor in children requiring cardiopulmonary bypass. There was limited correlation between TEG-PM and MEIA results which raises a concern about the accuracy of these tests at the ADP receptor. Lower pre-operative TEG-PM ADP MA may predict intra-operative platelet transfusions; however, larger studies are needed to determine the utility of TEG-PM and MEIA in guiding platelet transfusions in this population.
- 12 December 2019
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 7, 509
Open AccessTEG Platelet Mapping and Impedance Aggregometry to Predict Platelet Transfusion During Cardiopulmonary Bypass in Pediatric Patients
Background: Cardiopulmonary bypass-related platelet dysfunction can increase the risk of intra- and post-operative bleeding in children undergoing cardiac surgery. More accurate laboratory tests that identify acquired platelet abnormalities could allow for rapid identification of patients at risk of bleeding and provide therapies that could reduce bleeding and platelet transfusions. We hypothesized that thromboelastography with platelet mapping (TEG-PM) and multiple electrode impedance aggregometry (MEIA) as functional measures of platelet function would predict who will require platelet transfusion. Our secondary hypothesis was that platelet aggregation at both arachidonic acid (AA) and adenosine diphosphate (ADP) receptors would correlate between TEG-PM and MEIA results. Methods: In this prospective study from August 2013 to December 2015, children from newborn to 5 years of age with congenital heart disease undergoing cardiopulmonary bypass had blood samples collected and analyzed at four time points: pre-bypass, post-bypass, post-operatively on arrival to the Cardiac Intensive Care Unit, and 24 h after arrival. Results: Of the 44 patients analyzed, the 10 patients who received peri-operative platelet transfusion were significantly younger (p = 0.05), had higher STAT (Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery) Mortality Categories (p < 0.002) and longer cardiopulmonary bypass times (p = 0.02). In univariate analysis, four variables were associated with peri-operative platelet transfusion: pre-operative age [OR 0.95 (0.93, 0.98), p = 0.03], cardiopulmonary bypass time [1.5 (1.31, 1.68), p = 0.008], STAT Mortality Category [3.64 (3.40, 3.87), p < 0.001], and TEG-PM ADP [0.79 (0.65, 0.93), p = 0.04]. ROC analysis demonstrated moderate predictive value of TEG-PM ADP with AUC of 0.745 (0.59, 0.91). A TEG-PM ADP value of less than or equal to 21 had 85% sensitivity and 70% specificity for platelet transfusion. In the multivariate analysis, only STAT Mortality Category predicted platelet transfusion. TEG-PM and MEIA results correlated for the AA receptor at all 4 time points, but the same tests at the ADP receptors did not correlate. Conclusions: TEG-PM ADP may provide more clinically relevant information regarding platelet function compared to the MEIA at the ADP receptor in children requiring cardiopulmonary bypass. There was limited correlation between TEG-PM and MEIA results which raises a concern about the accuracy of these tests at the ADP receptor. Lower pre-operative TEG-PM ADP MA may predict intra-operative platelet transfusions; however, larger studies are needed to determine the utility of TEG-PM and MEIA in guiding platelet transfusions in this population.
- 1 September 2019
- Published by Elsevier in Resuscitation
- Vol. 142, 74-80
Inadequate oxygen delivery index dose is associated with cardiac arrest risk in neonates following cardiopulmonary bypass surgery
- 1 September 2019
- Published by Elsevier in Resuscitation
- Vol. 142, 74-80
Inadequate oxygen delivery index dose is associated with cardiac arrest risk in neonates following cardiopulmonary bypass surgery
- 4 January 2019
- Published by Wiley in Pediatric Transplantation
- Vol. 23 (2) , e13340
Moderate‐severe primary graft dysfunction after pediatric heart transplantation
Background: PGD is a complication after heart transplantation (OHT) and a significant cause of mortality, particularly in infant recipients. Lack of standardized definition of PGD in the pediatric population makes the prevalence and magnitude of impact unclear.Methods: ISHLT PGD consensus guidelines, which include inotrope scores and need for MCS, were applied retrospectively to 208 pediatric OHT recipients from a single institution from 1/2005‐5/2016. PGD was defined as: moderate PGD—inotrope score >10 on postoperative day 1 (24‐48 hours), and severe PGD—MCS within 24 hours (in the absence of detectable rejection).Results: PGD occurred in 34 patients (16.3%); 14 of which had severe PGD (6.7%). Multivariate risk factors for PGD included CPB time (OR 10.3/10 min, 95% 10.05, 10.2, P = 0.03), Fontan palliation (OR 1.9, 95% 1.2, 3.97), and PCM (OR 5.65, 95% 1.52, 22.4); but not age, weight, ischemic time, or donor characteristics. Upon sub‐analysis excluding patients with PCM, increased CPB was a significant multivariate risk factor (OR 10.09, 95% 9.89, 10.12, P = 0.003). Patients with PGD had decreased discharge survival compared to those without PGD (85% vs 96%, P < 0.01). Severe PGD was associated with the poorest 1‐year survival (57% vs 91% without PGD, P = 0.04).Conclusion: Patients with prolonged CPB are potentially at risk for developing PGD. Neither infant recipients nor donor characteristics were associated with an increased risk of PGD in the current era.
- 4 January 2019
- Published by Wiley in Pediatric Transplantation
- Vol. 23 (2) , e13340
Moderate‐severe primary graft dysfunction after pediatric heart transplantation
Background: PGD is a complication after heart transplantation (OHT) and a significant cause of mortality, particularly in infant recipients. Lack of standardized definition of PGD in the pediatric population makes the prevalence and magnitude of impact unclear.Methods: ISHLT PGD consensus guidelines, which include inotrope scores and need for MCS, were applied retrospectively to 208 pediatric OHT recipients from a single institution from 1/2005‐5/2016. PGD was defined as: moderate PGD—inotrope score >10 on postoperative day 1 (24‐48 hours), and severe PGD—MCS within 24 hours (in the absence of detectable rejection).Results: PGD occurred in 34 patients (16.3%); 14 of which had severe PGD (6.7%). Multivariate risk factors for PGD included CPB time (OR 10.3/10 min, 95% 10.05, 10.2, P = 0.03), Fontan palliation (OR 1.9, 95% 1.2, 3.97), and PCM (OR 5.65, 95% 1.52, 22.4); but not age, weight, ischemic time, or donor characteristics. Upon sub‐analysis excluding patients with PCM, increased CPB was a significant multivariate risk factor (OR 10.09, 95% 9.89, 10.12, P = 0.003). Patients with PGD had decreased discharge survival compared to those without PGD (85% vs 96%, P < 0.01). Severe PGD was associated with the poorest 1‐year survival (57% vs 91% without PGD, P = 0.04).Conclusion: Patients with prolonged CPB are potentially at risk for developing PGD. Neither infant recipients nor donor characteristics were associated with an increased risk of PGD in the current era.
- 1 November 2018
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 19 (11) , 1083-1084
Outcome Prediction Following Complex Congenital Heart Disease Operations—The Intensivist Perspective*
- 1 November 2018
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 19 (11) , 1083-1084
Outcome Prediction Following Complex Congenital Heart Disease Operations—The Intensivist Perspective*
- 11 July 2018
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 28 (9) , 1175-1177
Successful preoperative bridge with extracorporeal membrane oxygenation in three neonates with D-transposition of the great vessels and pulmonary hypertension
Pulmonary hypertension with transposition of the great arteries is associated with significant morbidity and mortality. At the worst end of the spectrum are patients who undergo extracorporeal support perioperatively. We describe our experience with three patients who received preoperative extracorporeal support and separated from cardiopulmonary bypass successfully on conventional postoperative care, with no significant deficits on follow-up.
- 11 July 2018
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 28 (9) , 1175-1177
Successful preoperative bridge with extracorporeal membrane oxygenation in three neonates with D-transposition of the great vessels and pulmonary hypertension
Pulmonary hypertension with transposition of the great arteries is associated with significant morbidity and mortality. At the worst end of the spectrum are patients who undergo extracorporeal support perioperatively. We describe our experience with three patients who received preoperative extracorporeal support and separated from cardiopulmonary bypass successfully on conventional postoperative care, with no significant deficits on follow-up.
- 1 November 2017
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 104 (5) , 1630-1636
A Novel Surgical Approach to Mechanical Circulatory Support in Univentricular Infants
- 1 November 2017
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 104 (5) , 1630-1636
A Novel Surgical Approach to Mechanical Circulatory Support in Univentricular Infants
- 1 October 2017
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 18 (10) , 949-957
Epidemiology of Noninvasive Ventilation in Pediatric Cardiac ICUs*
Objective: To describe the epidemiology of noninvasive ventilation therapy for patients admitted to pediatric cardiac ICUs and to assess practice variation across hospitals. Design: Retrospective cohort study using prospectively collected clinical registry data. Setting: Pediatric Cardiac Critical Care Consortium clinical registry. Patients: Patients admitted to cardiac ICUs at PC4 hospitals. Interventions: None. Measurements and Main Results: We analyzed all cardiac ICU encounters that included any respiratory support from October 2013 to December 2015. Noninvasive ventilation therapy included high flow nasal cannula and positive airway pressure support. We compared patient and, when relevant, perioperative characteristics of those receiving noninvasive ventilation to all others. Subgroup analysis was performed on neonates and infants undergoing major cardiovascular surgery. To examine duration of respiratory support, we created a casemix-adjustment model and calculated adjusted mean durations of total respiratory support (mechanical ventilation + noninvasive ventilation), mechanical ventilation, and noninvasive ventilation. We compared adjusted duration of support across hospitals. The cohort included 8,940 encounters from 15 hospitals: 3,950 (44%) received noninvasive ventilation and 72% were neonates and infants. Medical encounters were more likely to include noninvasive ventilation than surgical. In surgical neonates and infants, 2,032 (55%) received postoperative noninvasive ventilation. Neonates, extracardiac anomalies, single ventricle, procedure complexity, preoperative respiratory support, mechanical ventilation duration, and postoperative disease severity were associated with noninvasive ventilation therapy (p < 0.001 for all). Across hospitals, noninvasive ventilation use ranged from 32% to 65%, and adjusted mean noninvasive ventilation duration ranged from 1 to 4 days (3-d observed mean). Duration of total adjusted respiratory support was more strongly correlated with duration of mechanical ventilation compared with noninvasive ventilation (Pearson r = 0.93 vs 0.71, respectively). Conclusions: Noninvasive ventilation use is common in cardiac ICUs, especially in patients admitted for medical conditions, infants, and those undergoing high complexity surgery. We observed wide variation in noninvasive ventilation use across hospitals, though the primary driver of total respiratory support time seems to be duration of mechanical ventilation.
- 1 October 2017
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 18 (10) , 949-957
Epidemiology of Noninvasive Ventilation in Pediatric Cardiac ICUs*
Objective: To describe the epidemiology of noninvasive ventilation therapy for patients admitted to pediatric cardiac ICUs and to assess practice variation across hospitals. Design: Retrospective cohort study using prospectively collected clinical registry data. Setting: Pediatric Cardiac Critical Care Consortium clinical registry. Patients: Patients admitted to cardiac ICUs at PC4 hospitals. Interventions: None. Measurements and Main Results: We analyzed all cardiac ICU encounters that included any respiratory support from October 2013 to December 2015. Noninvasive ventilation therapy included high flow nasal cannula and positive airway pressure support. We compared patient and, when relevant, perioperative characteristics of those receiving noninvasive ventilation to all others. Subgroup analysis was performed on neonates and infants undergoing major cardiovascular surgery. To examine duration of respiratory support, we created a casemix-adjustment model and calculated adjusted mean durations of total respiratory support (mechanical ventilation + noninvasive ventilation), mechanical ventilation, and noninvasive ventilation. We compared adjusted duration of support across hospitals. The cohort included 8,940 encounters from 15 hospitals: 3,950 (44%) received noninvasive ventilation and 72% were neonates and infants. Medical encounters were more likely to include noninvasive ventilation than surgical. In surgical neonates and infants, 2,032 (55%) received postoperative noninvasive ventilation. Neonates, extracardiac anomalies, single ventricle, procedure complexity, preoperative respiratory support, mechanical ventilation duration, and postoperative disease severity were associated with noninvasive ventilation therapy (p < 0.001 for all). Across hospitals, noninvasive ventilation use ranged from 32% to 65%, and adjusted mean noninvasive ventilation duration ranged from 1 to 4 days (3-d observed mean). Duration of total adjusted respiratory support was more strongly correlated with duration of mechanical ventilation compared with noninvasive ventilation (Pearson r = 0.93 vs 0.71, respectively). Conclusions: Noninvasive ventilation use is common in cardiac ICUs, especially in patients admitted for medical conditions, infants, and those undergoing high complexity surgery. We observed wide variation in noninvasive ventilation use across hospitals, though the primary driver of total respiratory support time seems to be duration of mechanical ventilation.